Perhaps it was inevitable that with Food and Drug Administration Commissioner Scott Gottlieb speaking before an auditorium full of biotechnology executives, a particularly contentious topic would come up: the new right-to-try law.
{iframe}https://medcitynews.com/2018/06/gottlieb-at-bio-fda-developing-processes-around-right-to-try-law/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=63610846&_hsenc=p2ANqtz–miWqAm6lMJANb2jY2n8dEYnWGkmclzErhY0Xqi_1QdeWaoUCu5PcaY2zbl_XkLnK5PcG8QGKxsmyh4BlIq8HTruoRSg&_hsmi=63610846{/iframe}